Trials / Completed
CompletedNCT05528536
Acceptance and Commitment Therapy and Exercise for Older Adults With Chronic Pain
Investigation of the Effect of Acceptance and Commitment Therapy and Exercise in Older Adults With Chronic Pain: A Randomized Controlled Trial
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 163 (actual)
- Sponsor
- The University of Hong Kong · Academic / Other
- Sex
- All
- Age
- 60 Years
- Healthy volunteers
- Not accepted
Summary
The goal of this trial is to learn if combining Acceptance and Commitment Therapy (ACT) and exercise works to reduce pain intensity, pain interference, and depressive symptoms in older adults with chronic pain and depressive symptoms. Researchers will compare ACT + exercise intervention (ACEx) to ACT + art intervention (Art+Ex) and usual care to see if ACT + exercise intervention works to reduce pain intensity, pain interference, and depressive symptoms. Participants will receive ACEx program, Art+Ex program, or usual care for 8 weeks and complete tests before and after the programs.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | Acceptance and Commitment Therapy (ACT) | A two-hour ACT will focus on enhancing participant's psychological flexibility towards pain. All sessions will be delivered face-to-face within their local community centre. |
| OTHER | Art | To be comparable with the experimental group, the Art session will be a two-hour long session which aims to share different art techniques, without any active components. All sessions will be delivered face-to-face within their local community centre. |
| OTHER | Exercise | An hour of low-to-moderate resistance exercise aims to increase their strength and balance. All sessions will be delivered face-to-face within their local community centre. |
| OTHER | Treatment as usual | treatment as usual within their community centres |
Timeline
- Start date
- 2022-05-15
- Primary completion
- 2023-12-31
- Completion
- 2024-01-19
- First posted
- 2022-09-06
- Last updated
- 2025-07-14
Locations
1 site across 1 country: Hong Kong
Source: ClinicalTrials.gov record NCT05528536. Inclusion in this directory is not an endorsement.